INDUSTRY NEWS Venture Funding Stabilizes, Shifts to Biotech, Shuns Energy Venture-capital funding for startup companies stabilized in the fourth quarter, with investor interest shifting toward drug development and away from clean energy. [Bloomberg Press Release] Osiris Completes Enrollment in Stem Cell Trial for Type 1 Diabetes Osiris Therapeutics, Inc. announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation for completing enrollment in a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem cell therapy, as a treatment for patients recently diagnosed with type 1 diabetes. [Osiris Therapeutics, Inc. Press Release] The Automation Partnership Begins New Five Year Collaboration with Top Regenerative Medicine Centre Following an Injection of £5.3 Million from the United Kingdom Government The Automation Partnership announced recently that its collaboration with leading translational research group, the Engineering and Physical Sciences Research Council Centre for Innovative Manufacturing in Regenerative Medicine at Loughborough University is to continue into a second five year phase. [The Automation Partnership Press Release] Aastrom Biosciences Announces Closing of Unit Offering Aastrom Biosciences, Inc. announced the closing of its previously announced underwritten public offering from which the Company received approximately $12.4 million in net proceeds from the sale of the units (including the partially exercised option of the over-allotment), after underwriting discounts and commissions and other offering expenses. [Aastrom Biosciences, Inc. Press Release] Stem Cell Assurance Announces a Financing and Marketing Partnership with MDwerks Stem Cell Assurance, Inc. and MDwerks, Inc. announced a financing and marketing partnership wherein MDwerks, through its Xeni Finance subsidiary, has provided the first tranche of financing to Stem Cell for the purchase of various medical devices from Cytori Therapeutics, Inc. [Stem Cell Assurance, Inc. Press Release] Scientific Breakthrough: Baltimore’s Bioparks Enjoy a Growth Spurt Companies are taking more space in Baltimore’s two emerging biotechnology research centers; at least one firm is mulling a venture capital-backed funding round; and plans to expand the University of Maryland, Baltimore’s biopark are still on the table. [Baltimore Business Journal] Can Miromatrix “Regenerate” Minnesota’s Medical Industry? Miromatrix Inc. has one official employee, zero money, and nothing yet to develop, never mind sell. But make no mistake: Everyone wants a piece of it. [MedCity News]
|